CKD Bio Corp. | |
Stock Exchange | Korea Exchange Commodity Market |
EPS |
KRW1575.18 |
Market Cap |
KRW140.29 B |
Shares Outstanding |
5.23 M |
Public Float |
3.18 M |
Address |
Chongkundang Building Seoul SL 03742 Korea, Republic Of |
Employees | - |
Website | http://www.ckdbio.com |
Updated | 07/08/2019 |
CKD Bio Corp. engages in the manufacture and sale of raw material medicine. Its products include potassium clavulanate, demeclocycline, rifampicin, and acarbose. The company was founded on November 12, 2001 and is headquartered in Seoul, South Korea. |